174 related articles for article (PubMed ID: 9737891)
1. Resolution of severe Kaposi's sarcoma after initiation of antiretroviral triple therapy.
Jung C; Bogner JR; Goebel F
Eur J Med Res; 1998 Sep; 3(9):439-42. PubMed ID: 9737891
[TBL] [Abstract][Full Text] [Related]
2. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK;
Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
[TBL] [Abstract][Full Text] [Related]
3. Regression of AIDS-related Kaposi's sarcoma following combined antiretroviral treatment.
Monticelli A; Lewi D; Salomon H; Pampuro S; Libonatti O; Jauregui Rueda H; Hodara V
Rev Argent Microbiol; 2000; 32(4):206-8. PubMed ID: 11149154
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.
Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Boonyaprawit P
Antivir Ther; 2005; 10(8):911-6. PubMed ID: 16430196
[TBL] [Abstract][Full Text] [Related]
5. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
[TBL] [Abstract][Full Text] [Related]
6. [Observational study on the efficacy of the application of two classical regimens of triple antiretroviral therapy].
Eiros Bouza JM; Ortega Lafont M; Ortiz de Lejarazu R; Bachiller Luque P; de Luis Román DA
An Med Interna; 2003 May; 20(5):239-42. PubMed ID: 12831297
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma.
Fumagalli L; Zucchetti M; Parisi I; Viganò MG; Zecca B; Careddu A; D'Incalci M; Lazzarin A
Cancer Chemother Pharmacol; 2000; 45(6):495-501. PubMed ID: 10854138
[TBL] [Abstract][Full Text] [Related]
8. Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine.
Coplan PM; Cook JR; Carides GW; Heyse JF; Wu AW; Hammer SM; Nguyen BY; Meibohm AR; DiNubile MJ;
Clin Infect Dis; 2004 Aug; 39(3):426-33. PubMed ID: 15307012
[TBL] [Abstract][Full Text] [Related]
9. Improvement of onychomycosis without antifungal therapy after initiation of highly active anti-retroviral therapy (HAART) in an HIV-infected patient.
Tachikawa N; Yasuoka A; Oka S
Jpn J Infect Dis; 1999 Dec; 52(6):245-6. PubMed ID: 10738363
[No Abstract] [Full Text] [Related]
10. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
[TBL] [Abstract][Full Text] [Related]
11. Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks.
Murphy RL
Antivir Ther; 1999; 4 Suppl 3():85-7. PubMed ID: 16021877
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
[TBL] [Abstract][Full Text] [Related]
13. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.
Loke WC; Spittle MF; Mitchell S; Kulasegaram R
Int J STD AIDS; 2006 Aug; 17(8):565-6. PubMed ID: 16925908
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma.
Lebbé C; Blum L; Pellet C; Blanchard G; Vérola O; Morel P; Danne O; Calvo F
AIDS; 1998 May; 12(7):F45-9. PubMed ID: 9619797
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Gill PS
Semin Oncol; 1991 Oct; 18(5 Suppl 7):53-7. PubMed ID: 1719642
[TBL] [Abstract][Full Text] [Related]
17. [Effects of double and triple antiretroviral agents on the HCV viral load in patients coinfected with HIV and HCV].
Gavazzi G; Richallet G; Morand P; Bouchard O; Bosseray A; Leclercq P; Micoud M
Pathol Biol (Paris); 1998 Jun; 46(6):412-5. PubMed ID: 9769871
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma regression following treatment with a triple antiretroviral regimen containing nevirapine.
Shaw AJ; McLean KA
Int J STD AIDS; 1999 Jun; 10(6):417-8. PubMed ID: 10414887
[No Abstract] [Full Text] [Related]
19. Patterns of lymphotropic herpesvirus viraemia in HIV-infected patients with Kaposi's sarcoma treated with highly active antiretroviral therapy and liposomal daunorubicin.
Torre-Cisneros J; Pozo F; Serrano R; Vidal E; Rivero A; Tenorio A
AIDS; 2000 Sep; 14(14):2215-7. PubMed ID: 11061671
[No Abstract] [Full Text] [Related]
20. [Kaposi sarcoma in HIV patients: Response to antiretroviral treatment and chemotherapy].
Lasso M; Pérez J; Noriega L; Malebrán A; Espinoza S
Rev Med Chil; 2003 May; 131(5):483-90. PubMed ID: 12879808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]